Kampanjeplan Maravai LifeSciences Holdings, Inc.
Avansert tidsplan
Enkel graf
Om selskapet
Maravai LifeSciences Holdings, Inc. работает как медико-биологическая компания, которая предоставляет продукты, позволяющие разрабатывать лекарственные препараты, диагностику, новые вакцины и поддерживать исследования болезней человека. Продукция компании предназначена для ключевых этапов биофармацевтической разработки и включает нуклеиновые кислоты для диагностических и терапевтических применений, продукты на основе антител для обнаружения примесей при производстве биофармацевтических продуктов и продукты для обнаружения экспрессии белков в тканях различных видов. Flere detaljerEBITDA | 0.0485 |
---|---|
EV/EBITDA | 7.53 |
IPO date | 2020-11-20 |
ISIN | US56600D1072 |
Industry | Life Sciences Tools & Services |
P/BV | 16.86 |
P/E | 33.94 |
P/S | 9.19 |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Выручка | 0.1431 |
Див.доход ао | 0 |
Сайт | http://www.maravai.com |
Цена ао | 8.16 |
Число акций ао | 0.13192 млрд |
Prisendring per dag: | 0% (5.33) |
---|---|
Prisendring per uke: | -1.84% (5.43) |
Prisendring per måned: | -5.16% (5.62) |
Prisendring over 3 måneder: | -36.24% (8.36) |
Prisendring over seks måneder: | -23.2% (6.94) |
Prisendring per år: | -20.68% (6.72) |
Prisendring over 3 år: | -84.23% (33.79) |
Prisendring over 5 år: | 0% (5.33) |
Prisendring over 10 år: | 0% (5.33) |
Prisendring siden begynnelsen av året: | -18.63% (6.55) |
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
Institusjoner | Volum | Dele, % |
---|---|---|
GTCR, LLC | 21681033 | 16.39 |
12 West Capital Management LP | 11602988 | 8.77 |
Vanguard Group Inc | 10003894 | 7.56 |
Blackrock Inc. | 6481668 | 4.9 |
Massachusetts Financial Services Co. | 6014575 | 4.55 |
Millennium Management LLC | 5786849 | 4.37 |
Mackenzie Financial Corporation | 5169176 | 3.91 |
Braidwell LP | 5040635 | 3.81 |
AQR Capital Management, LLC | 3504111 | 2.65 |
Alyeska Investment Group, L.P. | 3196489 | 2.42 |
ETF | Dele, % | Lønnsomhet for året, % | Utbytte, % |
---|---|---|---|
Direxion mRNA ETF | 4.55 | ||
First Trust Active Factor Small Cap ETF | 0.22441 | 34.251150665961 | 1.61948 |
Avantis Responsible U.S. Equity ETF | 0.00011 | 26.778312788906 | 1.45257 |
Avantis U.S. Equity ETF | 0.00027 | 19.280363502395 | 1.59151 |
JPMorgan BetaBuilders U.S. Small Cap Equity Fund | 0.06378 | 24.74842126706 | 1.59225 |
ProShares Ultra Nasdaq Biotechnology | 0.08085 | 51.697637072723 | 0.85651 |
BNY Mellon US Small Cap Core Equity ETF | 0.05126 | 30.067895247333 | 1.75333 |
Dimensional U.S. Core Equity 2 ETF | 0.0017 | 30.755198832543 | 1.47098 |
Dimensional US Core Equity Market ETF | 0.00148 | 30.983243755928 | 1.40618 |
Dimensional U.S. Equity ETF | 0.00074 | 31.530984204131 | 1.3557 |
WisdomTree U.S. SmallCap Fund | 0.10903 | 8.3066022311694 | 1.80258 |
Vanguard ESG U.S. Stock ETF | 0 | 25.55450684285 | 1.26927 |
Fidelity MSCI Health Care Index ETF | 0.01558 | 2.0596036823217 | 1.46057 |
Fidelity Small-Mid Multifactor ETF | 0.09472 | 32.307692307692 | 1.59943 |
Goldman Sachs Innovate Equity ETF | 0.07195 | 29.658020073179 | 1.20987 |
ProShares Hedge Replication ETF | 0.00619 | 5.9237999659878 | 1.47892 |
Humankind US Stock ETF | 0.01499 | 18.809430395549 | 1.99919 |
Invesco Nasdaq Biotechnology ETF | 0.11324 | 28.578975171685 | 0.8565 |
iShares Morningstar Small-Cap ETF | 0.02051 | 30.095066471445 | 1.60498 |
iShares Morningstar Small-Cap Growth ETF | 0.03994 | 33.628071953382 | 0.72598 |
iShares Russell 2000 Growth ETF | 0.06816 | 38.042556988 | 0.6026 |
iShares Russell 3000 ETF | 0.00171 | 23.534583821805 | 1.43482 |
iShares Morningstar Small-Cap ETF | 0.02051 | 391.25300933451 | 1.60498 |
iShares Morningstar Small-Cap Growth ETF | 0.03994 | 598.0472297911 | 0.72598 |
SPDR S&P Kensho New Economies Composite ETF | 0.09442 | 10.220226641009 | 0.88486 |
Invesco FTSE RAFI US 1500 Small-Mid ETF | 0.05767 | 11.828814460393 | 1.75869 |
Schwab U.S. Small-Cap ETF | 0.02718 | 9.7741186404898 | 1.51433 |
Schwab U.S. Broad Market ETF | 0.00187 | 23.805868073765 | 1.43354 |
SPDR Portfolio MSCI Global Stock Market ETF | 0.00079 | 15.308042654158 | 2.19607 |
Royce Quant Small‑Cap Quality Value ETF | 0.48816 | 21.829200353285 | 1.62596 |
ProShares UltraPro Russell2000 | 0.02013 | 89.821266282945 | 1.47873 |
Vanguard Russell 3000 ETF | 0 | 31.87314172448 | 1.43817 |
Vanguard Russell 2000 Growth ETF | 0.07 | 14.283381416363 | 0.60264 |
Vanguard Russell 2000 ETF | 0.04 | 10.653723273532 | 1.48801 |
Principal Healthcare Innovators ETF | 0.11592 | 618.4964157054 | 0.8416 |
Future Tech ETF | 0.11592 | 426.33969118983 | 0.8416 |
БПИФ ТИНЬКОФФ БИОТЕХ | 0.14 | -8.9812332439678 | |
Veileder | Stillingstittel | Betaling | Fødselsår |
---|---|---|---|
Mr. Carl W. Hull | Co-Founder & Executive Chairman | 1.45M | 1959 (65 år) |
Mr. Kevin M. Herde | Executive VP & CFO | 778.28k | 1972 (52 år) |
Ms. Debra Hart | Senior Director of Investor Relations | N/A | |
Mr. Kurt Oreshack | Executive VP, General Counsel & Secretary | 701.4k | 1981 (43 år) |
Ms. Christine Dolan | Executive VP & GM of Cygnus Technologies | 755.97k | 1968 (56 år) |
Dr. Peter Michael Leddy Ph.D. | Executive VP & Chief Administrative Officer | 757k | 1963 (61 år) |
Mr. William E. Martin III | CEO & Director | 2.07M | 1975 (49 år) |
Dr. Kate E. Broderick Ph.D. | Chief Innovation Officer | N/A | |
Mr. Andrew Burch | President of Nucleic Acid Production | 1969 (55 år) | |
Ms. Rebecca Buzzeo | Executive VP & Chief Commercial Officer |
Adresse: United States, San Diego, CA , 10770 Wateridge Circle - åpne i Google maps, åpne Yandex-kart
Nettsted: http://www.maravai.com
Nettsted: http://www.maravai.com